Judge To Consider Class In Pfizer's Neurontin Cases
Nearly three years after criminal charges were settled in Pfizer Inc.'s illegal marketing of the epilepsy drug Neurontin, a federal judge is considering whether or not to grant class action status...To view the full article, register now.
Already a subscriber? Click here to view full article